» Articles » PMID: 28271214

Long Non-coding RNA UCA1 Regulates the Expression of Snail2 by MiR-203 to Promote Hepatocellular Carcinoma Progression

Overview
Specialty Oncology
Date 2017 Mar 9
PMID 28271214
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Long non-coding RNA (LncRNA) urothelial carcinoma-associated 1 (UCA1) is reported to be dysregulated in hepatocellular carcinoma (HCC) progression. However, the functions of UCA1 in HCC still need further study. The aim is to detect the role of UCA1 involving in HCC cells proliferation and invasion, and epithelial-mesenchymal transition (EMT).

Methods: The quantitative real-time PCR was used to detect the UCA1 and miR-203 expression levels in 60 cases' HCC tissues and adjacent normal tissues. Western blotting analysis was performed to detect the EMT markers E-cadherin, Vimentin and transcription factor Snail1, Snail2 expression. Luciferase reporter assay, RNA immunoprecipitation (RIP) and pull-down assays were used to evaluate whether miR-203 was a target of UCA1.

Results: Our results showed that UCA1 was markedly upregulated in HCC tissues and higher UCA1 expression in HCC was positively associated with tumor size, vascular invasion and American Joint Committee on Cancer (AJCC) stage (P < 0.05). Furthermore, gain-of-function and loss-of-function analysis showed that UCA1 knockdown inhibited HCC cells proliferation and invasion in vitro and xenograft tumour growth in vivo. Moreover, UCA1 overexpression promoted cell epithelial-mesenchymal transition (EMT) in HCC via effectively sponging to miR-203 and thereby activating the expression of transcription factor Snail2.

Conclusions: Our results identified that UCA1/miR-203/Snail2 pathway might involve in HCC progression. Inhibition of UCA1 acted as a promising therapeutic target for HCC patients.

Citing Articles

Homeobox B9 promotes the invasion and metastasis of hepatocellular carcinoma cells via the EZH2-MIR203A-SNAI2 axis.

Zhang D, Qiu Y, Zhang W, Du D, Liu Y, Liu L J Transl Med. 2024; 22(1):918.

PMID: 39390614 PMC: 11465790. DOI: 10.1186/s12967-024-05690-x.


MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma.

Wei Q, Jin F, Wang Z, Li B, Cao W, Sun Z World J Gastroenterol. 2024; 30(11):1497-1523.

PMID: 38617454 PMC: 11008420. DOI: 10.3748/wjg.v30.i11.1497.


CASC19: An Oncogenic Long Non-coding RNA in Different Cancers.

Wu Y, Mou J, Zhou G, Yuan C Curr Pharm Des. 2024; 30(15):1157-1166.

PMID: 38544395 DOI: 10.2174/0113816128300061240319034243.


The role of long non-coding RNA in hepatocellular carcinoma.

Liang W, Zhao Y, Meng Q, Jiang W, Deng S, Xue J Aging (Albany NY). 2024; 16(4):4052-4073.

PMID: 38334963 PMC: 10929815. DOI: 10.18632/aging.205523.


The role of UCA1 and WRAP53 in diagnosis of hepatocellular carcinoma: A single-center case-control study.

Abdelmoety A, Elhassafy M, Said R, Elsheaita A, Mahmoud M Clin Exp Hepatol. 2023; 9(2):129-137.

PMID: 37502440 PMC: 10369654. DOI: 10.5114/ceh.2023.127569.


References
1.
Ni B, Yu X, Guo X, Fan X, Yang Z, Wu P . Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol. 2015; 47(4):1329-38. DOI: 10.3892/ijo.2015.3109. View

2.
Na X, Liu Z, Ren P, Yu R, Shang X . Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med. 2015; 8(8):12609-16. PMC: 4612857. View

3.
Gu Y, Chen T, Li G, Yu X, Lu Y, Wang H . LncRNAs: emerging biomarkers in gastric cancer. Future Oncol. 2015; 11(17):2427-41. DOI: 10.2217/fon.15.175. View

4.
Lai M, Yang Z, Zhou L, Zhu Q, Xie H, Zhang F . Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2011; 29(3):1810-6. DOI: 10.1007/s12032-011-0004-z. View

5.
Xue M, Pang H, Li X, Li H, Pan J, Chen W . Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci. 2015; 107(1):18-27. PMC: 4724815. DOI: 10.1111/cas.12844. View